StockData
Nkarta, Inc. logo

Nkarta, Inc. (NKTX) stock

NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$1.25+0.04 (+3.31%)

Close on Nov 17, 2026Market cap $89.53MP/E –Yield 0.00%

Nkarta total assets

Total assets on the balance sheet at the end of each period.

Nkarta's total assets was $337.65M at Jun 30, 2026. For fiscal 2025 it was $404.21M, down 19.4% from the year before. The highest annual figure on record is $501.20M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$404.21M-19.4%
FY2024Dec 31, 2024$501.20M+32.3%
FY2023Dec 31, 2023$378.89M-19.9%
FY2022Dec 31, 2022$472.94M+72.7%
FY2021Dec 31, 2021$273.90M-18.9%
FY2020Dec 31, 2020$337.65M+597.5%
FY2019Dec 31, 2019$48.41M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$337.65M-24.7%
Q1 FY2026Mar 31, 2026$372.07M-20.9%
Q4 FY2025Dec 31, 2025$404.21M-19.4%
Q3 FY2025Sep 30, 2025$427.24M-19.7%
Q2 FY2025Jun 30, 2025$448.31M-19.1%
Q1 FY2025Mar 31, 2025$470.61M-18.4%
Q4 FY2024Dec 31, 2024$501.20M+32.3%
Q3 FY2024Sep 30, 2024$532.03M+31.1%
Q2 FY2024Jun 30, 2024$554.09M+29.1%
Q1 FY2024Mar 31, 2024$576.94M+25.9%
Q4 FY2023Dec 31, 2023$378.89M-19.9%
Q3 FY2023Sep 30, 2023$405.86M-19.4%
Q2 FY2023Jun 30, 2023$429.04M-14.8%
Q1 FY2023Mar 31, 2023$458.17M+49.6%
Q4 FY2022Dec 31, 2022$472.94M+72.7%
Q3 FY2022Sep 30, 2022$503.80M+72.3%
Q2 FY2022Jun 30, 2022$503.64M+62.9%
Q1 FY2022Mar 31, 2022$306.30M-6.0%
Q4 FY2021Dec 31, 2021$273.90M-18.9%
Q3 FY2021Sep 30, 2021$292.47M-17.0%
Q2 FY2021Jun 30, 2021$309.11M+608.7%
Q1 FY2021Mar 31, 2021$325.69M+572.8%
Q4 FY2020Dec 31, 2020$337.65M–
Q3 FY2020Sep 30, 2020$352.30M–
Q2 FY2020Jun 30, 2020$43.62M–
Q4 FY2019Dec 31, 2019$48.41M–

More Nkarta figures

See a number that looks wrong?